Retevmo (Selpercatinib) Dosage: A Comprehensive Guide for Indian Patients

Understanding Retevmo (Selpercatinib) Dosage for Cancer Treatment in India Retevmo, with the active ingredient selpercatinib, is a targeted therapy drug used in the treatment of certain types of cancer, specifically certain forms of non-small cell lung cancer (NSCLC) and thyroid cancer. It belongs to a class of drugs known as RET inhibitors, which work by targeting specific genetic alterations (RET gene fusions or mutations) that drive the growth of these cancers. This article provides a detailed overview of Retevmo dosage, strengths, and how to take it, tailored for patients in India. It is crucial to remember that this information is for educational purposes and should not replace the advice of your oncologist. What is Retevmo and How Does it Work? Retevmo is a prescription medication available in capsule form. It is designed to target cancer cells that have specific genetic changes in the RET (Rearranged during Transfection) proto-oncogene. By inhibiting the RET pathway, Retevmo helps to slow down or stop the growth of cancer cells. It is used for: Locally advanced or metastatic non-small cell lung cancer (NSCLC) with a RET gene fusion. Advanced or metastatic medullary thyroid cancer (MTC) with a RET mutation. Advanced or metastatic thyroid cancer with a RET gene fusion or mutation that requires systemic therapy. It is also approved for use in children aged 12 years and older with certain types of thyroid cancer. Locally advanced means the cancer has spread beyond its original site but is still within the nearby region. Metastatic means the cancer has spread to distant parts of the body. Retevmo Strengths and Forms Retevmo is available in two strengths: 40 milligrams (mg) 80 mg The capsules are meant to be swallowed whole and should not be opened or crushed. Understanding Retevmo Dosage: Factors Influencing Treatment The dosage of Retevmo is highly individualized and is determined by several factors, primarily: Body Weight: Dosage is calculated based on a patient's weight in kilograms (kg) or pounds (lb). Type and Stage of Cancer: The specific type of cancer (NSCLC, MTC, or other thyroid cancers) and its extent of spread influence the prescribed dose. Patient's Response to Treatment: How well the patient tolerates the medication and whether the cancer is responding are key factors in dose adjustments. Presence of Side Effects: If a patient experiences significant side effects, the doctor may adjust the dosage. Your doctor will determine the most appropriate starting dose and will monitor you closely throughout the treatment to make any necessary adjustments. Recommended Dosage for Non-Small Cell Lung Cancer (NSCLC) For adults with locally advanced or metastatic NSCLC that has a RET gene fusion, the typical dosage is determined by body weight: If your body weight is less than 50 kg (approximately 110 lb): The usual dosage is 120 mg taken twice daily (every 12 hours). If your body weight is 50 kg (approximately 110 lb) or more: The usual dosage is 160 mg taken twice daily (every 12 hours). Patients typically continue this dosage until their cancer progresses or they experience side effects that cannot be managed. Recommended Dosage for Thyroid Cancer (MTC and other types) For adults with advanced or metastatic medullary thyroid cancer (MTC) or other types of advanced or metastatic thyroid cancer with a RET mutation or fusion, who require systemic therapy, the dosage is also based on body weight: If your body weight is less than 50 kg (approximately 110 lb): The usual dosage is 120 mg taken twice daily (every 12 hours). If your body weight is 50 kg (approximately 110 lb) or more: The usual dosage is 160 mg taken twice daily (every 12 hours). This dosage is generally continued until the cancer worsens or unacceptable side effects occur. Dosage for Children (12 years and older) Retevmo is also approved for certain thyroid cancers in children aged 12 years and older. The dosage for pediatric patients is also based on body weight and determined by their treating physician. The general guidelines for adults often serve as a reference, but specific pediatric dosing protocols will be followed. How to Take Retevmo It is essential to follow your doctor's instructions precisely when taking Retevmo: Take the capsules exactly as prescribed by your doctor. Take the medication twice a day, approximately every 12 hours. Swallow the capsules whole with water. Do not chew, crush, or open the capsules. You can take Retevmo with or without food. However, if you experience stomach upset, taking it with food might help. Try to take your doses at the same time(s) each day to maintain a consistent level of the drug in your body. If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. Potential Side Effects and Management Like all medications, Retevmo can cause side effects. Common side effects may include fatigue, diarrhea, dry mouth, headache, abdominal pain, and increased blood pressure. More serious side effects can also occur. It is vital to discuss any side effects you experience with your doctor promptly. They may adjust your dosage, prescribe medications to manage the side effects, or recommend other supportive care measures. When to Consult Your Doctor You should consult your doctor or oncologist immediately if you experience any of the following:

In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.